Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis

•The incidence of COVID-19 vaccine-related venous thrombosis was 28 per 100,000 doses•Common sites of thrombosis: cerebral vein (54%), deep vein/pulmonary thromboembolism (36%), splanchnic vein (19%)•Thrombosis after COVID-19 vaccination occurred more in women and in those aged

Saved in:
Bibliographic Details
Published in:International journal of infectious diseases 2022-06, Vol.119, p.130-139
Main Authors: Kim, Ah Young, Woo, Wongi, Yon, Dong Keon, Lee, Seung Won, Yang, Jae Won, Kim, Ji Hong, Park, Seoyeon, Koyanagi, Ai, Kim, Min Seo, Lee, Sungsoo, Shin, Jae Il, Smith, Lee
Format: Article
Language:English
Subjects:
adverse event
cerebral venous thrombosis
COVID-19 vaccine
splanchnic vein thrombosis
vaccine thrombosis
vaccine-induced immune thrombotic thrombocytopenia
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•The incidence of COVID-19 vaccine-related venous thrombosis was 28 per 100,000 doses•Common sites of thrombosis: cerebral vein (54%), deep vein/pulmonary thromboembolism (36%), splanchnic vein (19%)•Thrombosis after COVID-19 vaccination occurred more in women and in those aged
ISSN:1201-9712
1878-3511
DOI:10.1016/j.ijid.2022.03.034